Integra LifeSciences Cor... (IART)
NASDAQ: IART
· Real-Time Price · USD
13.20
0.02 (0.15%)
At close: Sep 26, 2025, 3:59 PM
13.20
0.00%
After-hours: Sep 26, 2025, 05:18 PM EDT
Integra LifeSciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Codman Specialty Surgical Revenue | 303.96M | 280.66M | 314.66M | 270.78M | 301.76M | 256.43M | 268.2M | 271.03M | 248.14M | 264.6M | 249.8M | 257.86M | 247.31M | 270.66M | 256.5M | 256.84M | 241.24M | 254.29M | 239.32M | 169.78M | 231.44M | 259.4M | 252.98M | 249.26M | 249.28M | 239.03M | 239.5M | 236.12M |
| Codman Specialty Surgical Revenue Growth | +8.30% | -10.80% | +16.20% | -10.27% | +17.68% | -4.39% | -1.04% | +9.23% | -6.22% | +5.93% | -3.13% | +4.27% | -8.63% | +5.52% | -0.13% | +6.46% | -5.13% | +6.25% | +40.96% | -26.64% | -10.78% | +2.53% | +1.49% | -0.01% | +4.28% | -0.20% | +1.44% | n/a |
| Tissue Technologies Revenue | 111.65M | 101.99M | 127.99M | 110.05M | 116.41M | 112.44M | 114.22M | 110.24M | 132.71M | 133.43M | 135.4M | 139.95M | 129.33M | 134.87M | 130.36M | 133.16M | 118.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Tissue Technologies Revenue Growth | +9.47% | -20.31% | +16.30% | -5.46% | +3.54% | -1.56% | +3.61% | -16.93% | -0.54% | -1.46% | -3.26% | +8.21% | -4.11% | +3.45% | -2.10% | +12.06% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Jun 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 47.73M | 45.1M | 44.07M | 37.05M | 45.95M | 49.55M | 48.78M | 47.71M | 50.47M | 42.62M | 42.77M | 43.37M | 47.72M | 45.42M | 45.02M | 44.31M | 47.3M | 43.24M | 40.47M | 33.5M | 39.96M | 42.58M | 42.08M | 37.03M | 35.7M | 35.95M | 37.02M | 35.5M | 35.78M | 32.61M | 32.5M | 28.82M | 28.55M | 31.66M | 29.44M | 24.27M | 27.5M | 26.76M | 23.85M | 25.85M | 25.32M | 21.54M | 23.78M | 23.62M | 20.35M | 22.88M | 23.67M | 10.77M | 11.63M |
| Asia Pacific Revenue Growth | +5.82% | +2.36% | +18.93% | -19.37% | -7.25% | +1.57% | +2.25% | -5.48% | +18.42% | -0.36% | -1.36% | -9.12% | +5.06% | +0.90% | +1.60% | -6.32% | +9.38% | +6.84% | +20.81% | -16.16% | -6.16% | +1.19% | +13.63% | +3.73% | -0.69% | -2.90% | +4.30% | -0.80% | +9.74% | +0.34% | +12.78% | +0.92% | -9.82% | +7.54% | +21.29% | -11.72% | +2.74% | +12.22% | -7.74% | +2.08% | +17.55% | -9.39% | +0.67% | +16.05% | -11.07% | -3.31% | +119.86% | -7.40% | n/a |
| Europe Revenue | 42.59M | 35.33M | 41.84M | 34.37M | 40.69M | 41.6M | 41.52M | 37.45M | 41.06M | 42M | 38.3M | 46.86M | 43.74M | 50.61M | 46.46M | 48.44M | 45.82M | 48.77M | 45.99M | 32.03M | 45.9M | 48.72M | 49.24M | 50.87M | 48.64M | 50.7M | 47.47M | 51.41M | 51.77M | 213.69M | 219.27M | 201.1M | 194.35M | 191.87M | 181.23M | 178.29M | 190.09M | 180.96M | 180.1M | 178.81M | 163.38M | 166.56M | 157.17M | 150.02M | 165.93M | n/a | n/a | 24.17M | 25.21M |
| Europe Revenue Growth | +20.57% | -15.57% | +21.75% | -15.53% | -2.18% | +0.17% | +10.87% | -8.80% | -2.22% | +9.65% | -18.27% | +7.13% | -13.57% | +8.94% | -4.09% | +5.71% | -6.05% | +6.04% | +43.62% | -30.22% | -5.79% | -1.07% | -3.20% | +4.59% | -4.07% | +6.81% | -7.65% | -0.71% | -75.77% | -2.55% | +9.04% | +3.47% | +1.29% | +5.87% | +1.65% | -6.21% | +5.05% | +0.48% | +0.72% | +9.44% | -1.91% | +5.97% | +4.76% | -9.59% | n/a | n/a | n/a | -4.13% | n/a |
| Rest Of The World Revenue | 18.97M | 20M | 336.03M | 290.19M | 310.23M | 256.23M | 269.84M | 276.78M | 271M | 294.1M | 282.02M | 287.35M | 263.35M | 287.77M | 275.77M | 278.19M | 247.79M | 276.8M | 266.48M | 181.85M | 246.85M | 280.98M | 266.28M | 273.39M | 256.73M | 276.38M | 260.87M | 259.71M | 248.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of The World Revenue Growth | -5.17% | -94.05% | +15.80% | -6.46% | +21.07% | -5.04% | -2.51% | +2.13% | -7.85% | +4.28% | -1.86% | +9.11% | -8.49% | +4.35% | -0.87% | +12.27% | -10.48% | +3.87% | +46.54% | -26.33% | -12.15% | +5.52% | -2.60% | +6.49% | -7.11% | +5.94% | +0.45% | +4.33% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 306.31M | 282.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +8.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 179.89M | 181.5M | 178.52M | 164.94M | 172.18M | 165.8M | 147.44M | 161.95M | 164.91M | 166.66M | 151.92M | 143.82M | 160.65M | 159.93M | 162.25M | 156.01M | 162.55M | 156.63M | 162.39M | 150.08M | 116.11M | 165.95M | 174.25M | 173.1M | 165.38M | 174.87M | 177.23M | 173.35M | 176.6M | 163.57M | 190.64M | 145.94M | 145.01M | 142.5M | 112.12M | 112.32M | 119.22M | 111.96M | 109.75M | 113.42M | 126.59M | 114.06M |
| Selling, General, and Administrative Revenue Growth | -0.89% | +1.67% | +8.24% | -4.21% | +3.85% | +12.45% | -8.96% | -1.79% | -1.05% | +9.70% | +5.63% | -10.48% | +0.45% | -1.43% | +4.00% | -4.02% | +3.78% | -3.55% | +8.21% | +29.26% | -30.04% | -4.76% | +0.67% | +4.67% | -5.43% | -1.33% | +2.23% | -1.84% | +7.97% | -14.20% | +30.62% | +0.64% | +1.77% | +27.09% | -0.18% | -5.79% | +6.49% | +2.01% | -3.24% | -10.40% | +10.98% | n/a |
| Research and Development Revenue | 27M | 24.73M | 31.21M | 27.43M | 25.03M | 26.96M | 24.31M | 26.6M | 26.59M | 26.72M | 26.78M | 24.74M | 25.59M | 24.09M | 24.73M | 25.83M | 20.12M | 22.37M | 22.18M | 19.46M | 14.93M | 20.82M | 24.64M | 19M | 17.63M | 18.32M | 20.3M | 20.31M | 19.11M | 18.32M | 17.18M | 15.03M | 15.75M | 15.49M | 13.9M | 15.12M | 14.68M | 14.45M | 13.87M | 13.94M | 13.89M | 12.56M |
| Research and Development Revenue Growth | +9.18% | -20.77% | +13.76% | +9.59% | -7.16% | +10.92% | -8.59% | +0.03% | -0.51% | -0.22% | +8.28% | -3.33% | +6.24% | -2.59% | -4.28% | +28.38% | -10.07% | +0.88% | +13.97% | +30.38% | -28.30% | -15.53% | +29.68% | +7.77% | -3.76% | -9.74% | -0.05% | +6.29% | +4.27% | +6.66% | +14.27% | -4.53% | +1.63% | +11.46% | -8.09% | +3.03% | +1.58% | +4.22% | -0.52% | +0.34% | +10.63% | n/a |